| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP, Chief Scientific Ofc, COO | Chief Operating Officer | Chief Operating Officer
1 company
Jim Wassil is EVP, Chief Scientific Ofc, COO at PCVX. From January 2021 to October 2026, the filings on record show 0 open-market purchases and 38 sales. Jim Wassil's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $8.8M at current prices.
Our model assigns Jim Wassil a middling insider score of 53/100, based on 31 past trades. Over a 12-month horizon, 50.0% of those trades were profitable, with an average 12-month return of -9.0%.
The PCVX filings lean toward selling, a net 179,087 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 3, 2024 | PCVX Vaxcyte, Inc. | Chief Operating Officer | Sell10b5-1 | 3,000 | $71.99 | $215,960.97 | -1.4% | +52.5% | -52.0% | |
| May 1, 2024 | PCVX Vaxcyte, Inc. | Chief Operating Officer | Sell10b5-1 | 3,000 | $61.65 | $184,942.01 | -1.4% | +25.4% | -44.7% | |
| Apr 1, 2024 | PCVX Vaxcyte, Inc. | Chief Operating Officer | Sell10b5-1 | 3,000 | $66.69 | $200,065.55 | -1.4% | +15.3% | -51.7% | |
| Mar 1, 2024 | PCVX Vaxcyte, Inc. | Chief Operating Officer | Sell10b5-1 | 3,000 | $73.71 | $221,133.89 | -1.3% | -2.1% | +1.8% | |
| Feb 1, 2024 | PCVX Vaxcyte, Inc. | Chief Operating Officer | Sale+OE10b5-1 | 3,000 | $73.88 | $221,626.16 | -1.7% | -15.6% | +16.9% | |
| Jan 2, 2024 | PCVX Vaxcyte, Inc. | Chief Operating Officer | Sale+OE10b5-1 | 3,000 | $63.91 | $191,740.69 | -1.7% | +6.0% | +32.3% | |
| Dec 1, 2023 | PCVX Vaxcyte, Inc. | Chief Operating Officer | Sale+OE10b5-1 | 3,000 | $52.14 | $156,407.72 | -1.7% | +37.2% | +75.3% | |
| Nov 1, 2023 | PCVX Vaxcyte, Inc. | Chief Operating Officer | Sale+OE10b5-1 | 3,000 | $47.26 | $141,778.31 | -1.7% | +40.3% | +121.6% | |
| Oct 2, 2023 | PCVX Vaxcyte, Inc. | Chief Operating Officer | Sale+OE10b5-1 | 3,000 | $50.43 | $151,297.90 | -1.7% | +28.3% | +135.6% | |
| Sep 1, 2023 | PCVX Vaxcyte, Inc. | Chief Operating Officer | Sale+OE10b5-1 | 3,000 | $52.82 | $158,447.03 | -1.7% | -2.5% | +52.1% |